IXJ:NYE-iShares Global Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 92.46

Change

+1.25 (+1.37)%

Market Cap

N/A

Volume

0.12M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+1.84 (+1.27%)

USD 37.98B
FHLC Fidelity® MSCI Health Care In..

+0.94 (+1.38%)

USD 2.70B
FXH First Trust Health Care AlphaD..

+1.73 (+1.67%)

USD 1.01B
XHE SPDR® S&P Health Care Equipme..

+1.51 (+1.83%)

USD 0.18B
IDNA iShares Genomics Immunology an..

+0.23 (+1.05%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

+0.57 (+1.85%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

+1.67 (+1.75%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.38 (+1.36%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+1.41 (+2.35%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.19 (+0.93%)

USD 6.67M

ETFs Containing IXJ

IXJ:AU iShares Global Healthcare.. 99.97 % 0.00 %

+0.04 (+0.03%)

USD 1.45B
XHC:CA iShares Global Healthcare.. 99.68 % 0.65 %

+0.98 (+0.03%)

CAD 0.57B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.55% 95% A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.55% 95% A 83% B
Trailing 12 Months  
Capital Gain 0.83% 48% F 43% F
Dividend Return 1.41% 100% F 26% F
Total Return 2.23% 62% D 35% F
Trailing 5 Years  
Capital Gain 65.05% 48% F 47% F
Dividend Return 9.76% 84% B 17% F
Total Return 74.81% 57% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 5.24% 67% D+ 51% F
Dividend Return 6.20% 71% C- 47% F
Total Return 0.96% 74% C 23% F
Risk Return Profile  
Volatility (Standard Deviation) 13.13% 76% C+ 71% C-
Risk Adjusted Return 47.23% 81% B- 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike